Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 6,74 M
EBIT 2017 -0,75 M
Net income 2017 -1,06 M
Debt 2017 -
Yield 2017 -
Sales 2018 8,04 M
EBIT 2018 -2,23 M
Net income 2018 -2,59 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 10,1x
Capi. / Sales2018 8,45x
Capitalization 67,9 M
More Financials
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of IntelGenx Technologies Cor
Trading Rating : - Investor Rating :
More Ratings
Latest news on INTELGENX TECHNOLOGIES COR
06/27 INTELGENX TECHNOLOGIES CORP. (OTCMKT : IGXT) Files An 8-K Other Events
06/27 INTELGENX TECHNOLOGIES CORP. : Other Events (form 8-K)
06/27 INTELGENX TECHNOLOGIES : Receives USPTO Notice of Allowance for Oral Film Dosage..
06/27 INTELGENX TECHNOLOGIES : Receives USPTO Notice of Allowance for Oral Film Dosage..
06/12 INTELGENX TECHNOLOGIES : Intel Genx Announces Issuance of US Patent for Topical ..
06/08 INTELGENX TECHNOLOGIES CORP. : Other Events (form 8-K)
06/08 INTELGENX TECHNOLOGIES : Announces Issuance of US Patent for Topical Oral Film T..
06/08 INTELGENX TECHNOLOGIES : Announces Issuance of US Patent for Topical Oral Film T..
05/11 INTELGENX TECHNOLOGIES : reports 1Q loss
05/11 INTELGENX TECHNOLOGIES CORP. (OTCMKT : IGXT) Files An 8-K Other Events
More news
Sector news : Generic Pharmaceuticals
06:52p UK blue chips led lower by Hargreaves as strong pound takes toll
06:40pDJVECTURA : In Asthma Collaboration With Novartis's Sandoz
05:33pDJGLAXOSMITHKLINE : Announces US Filing For Mepolizumab
01:10pDJMERCK AND : Today's Top Supply Chain and Logistics News From WSJ
08:35a Factbox - Companies hit by global ransomware attack on June 27
More sector news : Generic Pharmaceuticals
Advertisement
Income Statement Evolution
More Financials
Consensus 
Mean consensus BUY
Number of Analysts 1
Average target price 1,50 $
Spread / Average Target 44%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Horst G. Zerbe Chairman, President & Chief Executive Officer
André Godin Chief Financial Officer & Executive Vice President
Nadine Paiement Director-Research & Development
Bernd Josef Melchers Independent Director
John Archibald Troup Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
INTELGENX TECHNOLOGIES..68
OTSUKA HOLDINGS CO LTD-4.06%24 296
SUN PHARMACEUTICAL IND..-13.40%20 230
ONO PHARMACEUTICAL CO...-1.76%13 202
SHANGHAI FOSUN PHARMAC..36.39%11 127
ASPEN PHARMACARE HOLDI..-0.91%9 873
More Results